{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:49:04Z","timestamp":1790740144472,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,10]],"date-time":"2019-03-10T00:00:00Z","timestamp":1552176000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Chang Gung Memorial Hospital, Taiwan","award":["CMRPG1B0581"],"award-info":[{"award-number":["CMRPG1B0581"]}]},{"name":"Chang Gung Memorial Hospital, Taiwan","award":["CIRPG3B0042"],"award-info":[{"award-number":["CIRPG3B0042"]}]},{"name":"Chang Gung Memorial Hospital, Taiwan","award":["CMRPG3E0111"],"award-info":[{"award-number":["CMRPG3E0111"]}]},{"DOI":"10.13039\/100007225","name":"Ministry of Science and Technology","doi-asserted-by":"publisher","award":["103-2314-B-182A-018-MY3"],"award-info":[{"award-number":["103-2314-B-182A-018-MY3"]}],"id":[{"id":"10.13039\/100007225","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007225","name":"Ministry of Science and Technology","doi-asserted-by":"publisher","award":["104-2314- B-182A- 066 -MY3"],"award-info":[{"award-number":["104-2314- B-182A- 066 -MY3"]}],"id":[{"id":"10.13039\/100007225","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Formosan Medical Association"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.jfma.2019.03.005","type":"journal-article","created":{"date-parts":[[2019,3,28]],"date-time":"2019-03-28T04:57:12Z","timestamp":1553749032000},"page":"1099-1106","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"title":["Serum indoxyl sulfate predicts adverse cardiovascular events in patients with chronic kidney disease"],"prefix":"10.1016","volume":"118","author":[{"given":"Pei-Chun","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7342-335X","authenticated-orcid":false,"given":"Jason Chih-Hsiang","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2722-0164","authenticated-orcid":false,"given":"Chia-Ni","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6973-5908","authenticated-orcid":false,"given":"Cheng-Chia","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Ting","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0361-6348","authenticated-orcid":false,"given":"Pao-Hsien","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5908-403X","authenticated-orcid":false,"given":"George","family":"Kou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueh-An","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Wei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yung-Chang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jfma.2019.03.005_bib1","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1046\/j.1525-139X.2003.16025.x","article-title":"Clinical epidemiology of cardiovascular disease in chronic kidney disease prior to dialysis","volume":"16","author":"Levin","year":"2003","journal-title":"Semin Dial"},{"issue":"9","key":"10.1016\/j.jfma.2019.03.005_bib2","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.jfma.2017.04.026","article-title":"Novel insights into acute kidney injury-chronic kidney disease continuum and the role of renin-angiotensin system","volume":"116","author":"Chou","year":"2017","journal-title":"J Formos Med Assoc"},{"issue":"9","key":"10.1016\/j.jfma.2019.03.005_bib3","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.jfma.2016.04.008","article-title":"Autonomic dysfunction in chronic kidney disease: an old problem in a new era","volume":"115","author":"Chou","year":"2016","journal-title":"J Formos Med Assoc"},{"issue":"9","key":"10.1016\/j.jfma.2019.03.005_bib4","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.jfma.2018.05.020","article-title":"On-treatment lipid profiles to predict the cardiovascular outcomes in ASCVD patients comorbid with chronic kidney disease - the multi-center T-SPARCLE registry study","volume":"117","author":"Ho","year":"2018","journal-title":"J Formos Med Assoc"},{"issue":"9","key":"10.1016\/j.jfma.2019.03.005_bib5","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1681\/ASN.2013101062","article-title":"The uremic toxicity of indoxyl sulfate and p-cresyl sulfate: a systematic review","volume":"25","author":"Vanholder","year":"2014","journal-title":"J Am Soc Nephrol \u2013 JASN (J Am Soc Nephrol)"},{"issue":"11","key":"10.1016\/j.jfma.2019.03.005_bib6","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1161\/CIRCRESAHA.112.278457","article-title":"Cardiorenal syndrome: the emerging role of protein-bound uremic toxins","volume":"111","author":"Lekawanvijit","year":"2012","journal-title":"Circ Res"},{"issue":"5 Suppl","key":"10.1016\/j.jfma.2019.03.005_bib7","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1053\/j.jrn.2010.05.002","article-title":"Indoxyl sulfate is a nephro-vascular toxin","volume":"20","author":"Niwa","year":"2010","journal-title":"J Ren Nutr \u2013 Off J Counc Renal Nutr Natl Kidney Found"},{"issue":"1","key":"10.1016\/j.jfma.2019.03.005_bib8","first-page":"31","article-title":"Diabetes and adverse cardiovascular outcomes in patients with acute coronary syndrome - data from Taiwan's acute coronary syndrome full spectrum data registry","volume":"32","author":"Wei","year":"2016","journal-title":"Acta Cardiol Sin"},{"issue":"10","key":"10.1016\/j.jfma.2019.03.005_bib9","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.2215\/CJN.03980609","article-title":"Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients","volume":"4","author":"Barreto","year":"2009","journal-title":"Clin J Am Soc Nephrol \u2013 CJASN"},{"issue":"9784","key":"10.1016\/j.jfma.2019.03.005_bib10","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1016\/S0140-6736(11)60739-3","article-title":"The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial","volume":"377","author":"Baigent","year":"2011","journal-title":"Lancet (London, England)"},{"issue":"3","key":"10.1016\/j.jfma.2019.03.005_bib11","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1056\/NEJMoa043545","article-title":"Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis","volume":"353","author":"Wanner","year":"2005","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.jfma.2019.03.005_bib12","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1093\/clinchem\/34.11.2264","article-title":"Accumulation of indoxyl sulfate, an inhibitor of drug-binding, in uremic serum as demonstrated by internal-surface reversed-phase liquid chromatography","volume":"34","author":"Niwa","year":"1988","journal-title":"Clin Chem"},{"issue":"11","key":"10.1016\/j.jfma.2019.03.005_bib13","first-page":"3693","article-title":"Serum protein-bound uraemic toxins and clinical outcomes in haemodialysis patients","volume":"25","author":"Lin","year":"2010","journal-title":"Nephrol Dial Transpl \u2013 Off Publ Eur Dial Transpl Assoc - Eur Renal Assoc"},{"issue":"7","key":"10.1016\/j.jfma.2019.03.005_bib14","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.arcmed.2013.09.007","article-title":"Gastrointestinal-related uremic toxins in peritoneal dialysis: a pilot study with a 5-year follow-up","volume":"44","author":"Lin","year":"2013","journal-title":"Arch Med Res"},{"issue":"7","key":"10.1016\/j.jfma.2019.03.005_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0132589","article-title":"Meta-analysis of the associations of p-cresyl sulfate (PCS) and indoxyl sulfate (IS) with cardiovascular events and all-cause mortality in patients with chronic renal failure","volume":"10","author":"Lin","year":"2015","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.jfma.2019.03.005_bib16","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.arcmed.2012.08.002","article-title":"Indoxyl sulfate predicts cardiovascular disease and renal function deterioration in advanced chronic kidney disease","volume":"43","author":"Lin","year":"2012","journal-title":"Arch Med Res"},{"issue":"2","key":"10.1016\/j.jfma.2019.03.005_bib17","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.005022","article-title":"Indoxyl sulfate: a novel cardiovascular risk factor in chronic kidney disease","volume":"6","author":"Hung","year":"2017","journal-title":"J Am Heart Assoc"},{"issue":"14","key":"10.1016\/j.jfma.2019.03.005_bib18","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1093\/eurheartj\/ehp574","article-title":"Does indoxyl sulfate, a uraemic toxin, have direct effects on cardiac fibroblasts and myocytes?","volume":"31","author":"Lekawanvijit","year":"2010","journal-title":"Eur Heart J"},{"issue":"7","key":"10.1016\/j.jfma.2019.03.005_bib19","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1093\/ndt\/gfp007","article-title":"Oral charcoal adsorbent (AST-120) prevents progression of cardiac damage in chronic kidney disease through suppression of oxidative stress","volume":"24","author":"Fujii","year":"2009","journal-title":"Nephrol Dial Transplant: Off Publ Eur Dial Transpl Assoc \u2013 Eur Renal Assoc"},{"issue":"7","key":"10.1016\/j.jfma.2019.03.005_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0041281","article-title":"Chronic kidney disease-induced cardiac fibrosis is ameliorated by reducing circulating levels of a non-dialysable uremic toxin, indoxyl sulfate","volume":"7","author":"Lekawanvijit","year":"2012","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.jfma.2019.03.005_bib21","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1111\/j.1538-7836.2007.02540.x","article-title":"The uremic solute indoxyl sulfate induces oxidative stress in endothelial cells","volume":"5","author":"Dou","year":"2007","journal-title":"J Thromb Haemost"},{"issue":"3","key":"10.1016\/j.jfma.2019.03.005_bib22","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/j.1538-7836.2005.01780.x","article-title":"Elevation of circulating endothelial microparticles in patients with chronic renal failure","volume":"4","author":"Faure","year":"2006","journal-title":"J Thromb Haemost"},{"issue":"2","key":"10.1016\/j.jfma.2019.03.005_bib23","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/j.1523-1755.2004.00399.x","article-title":"The uremic solutes p-cresol and indoxyl sulfate inhibit endothelial proliferation and wound repair","volume":"65","author":"Dou","year":"2004","journal-title":"Kidney Int"},{"issue":"10","key":"10.1016\/j.jfma.2019.03.005_bib24","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1038\/sj.ki.5000340","article-title":"Indoxyl sulfate stimulates proliferation of rat vascular smooth muscle cells","volume":"69","author":"Yamamoto","year":"2006","journal-title":"Kidney Int"},{"issue":"6","key":"10.1016\/j.jfma.2019.03.005_bib25","first-page":"1892","article-title":"Indoxyl sulphate promotes aortic calcification with expression of osteoblast-specific proteins in hypertensive rats","volume":"23","author":"Adijiang","year":"2008","journal-title":"Nephrol Dial Transpl \u2013 Off Publ Eur Dial Transpl Assoc - Eur Renal Assoc"},{"issue":"3","key":"10.1016\/j.jfma.2019.03.005_bib26","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1161\/CIRCULATIONAHA.112.118174","article-title":"Uremic serum and solutes increase post-vascular interventional thrombotic risk through altered stability of smooth muscle cell tissue factor","volume":"127","author":"Chitalia","year":"2013","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.jfma.2019.03.005_bib27","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.kint.2015.11.020","article-title":"Indoxyl sulfate suppresses endothelial progenitor cell-mediated neovascularization","volume":"89","author":"Hung","year":"2016","journal-title":"Kidney Int"},{"issue":"12","key":"10.1016\/j.jfma.2019.03.005_bib28","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.2215\/CJN.02940509","article-title":"p-Cresyl sulfate and indoxyl sulfate in hemodialysis patients","volume":"4","author":"Meijers","year":"2009","journal-title":"Clin J Am Soc Nephrol \u2013 CJASN"},{"issue":"11","key":"10.1016\/j.jfma.2019.03.005_bib29","doi-asserted-by":"crossref","first-page":"3430","DOI":"10.1681\/ASN.2005030310","article-title":"Removal of P-cresol sulfate by hemodialysis","volume":"16","author":"Martinez","year":"2005","journal-title":"J Am Soc Nephrol \u2013 JASN (J Am Soc Nephrol)"},{"issue":"11","key":"10.1016\/j.jfma.2019.03.005_bib30","first-page":"3115","article-title":"Review on uraemic solutes II--variability in reported concentrations: causes and consequences","volume":"22","author":"Vanholder","year":"2007","journal-title":"Nephrol Dial Transpl \u2013 Off Publ Eur Dial Transpl Assoc - Eur Renal Assoc"},{"issue":"1","key":"10.1016\/j.jfma.2019.03.005_bib31","first-page":"96","article-title":"Indoxyl sulfate, a circulating uremic toxin, stimulates the progression of glomerular sclerosis","volume":"124","author":"Niwa","year":"1994","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.jfma.2019.03.005_bib32","first-page":"S15","article-title":"Indoxyl sulfate increases the gene expressions of TGF-beta 1, TIMP-1 and pro-alpha 1(I) collagen in uremic rat kidneys","volume":"62","author":"Miyazaki","year":"1997","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.jfma.2019.03.005_bib33","first-page":"S23","article-title":"The protein metabolite hypothesis, a model for the progression of renal failure: an oral adsorbent lowers indoxyl sulfate levels in undialyzed uremic patients","volume":"62","author":"Niwa","year":"1997","journal-title":"Kidney Int Suppl"},{"issue":"2","key":"10.1016\/j.jfma.2019.03.005_bib34","doi-asserted-by":"crossref","first-page":"C389","DOI":"10.1152\/ajpcell.00206.2009","article-title":"ROS and PDGF-beta [corrected] receptors are critically involved in indoxyl sulfate actions that promote vascular smooth muscle cell proliferation and migration","volume":"297","author":"Shimizu","year":"2009","journal-title":"Am J Physiol Cell Physiol"},{"issue":"3","key":"10.1016\/j.jfma.2019.03.005_bib35","first-page":"938","article-title":"p-Cresyl sulphate and indoxyl sulphate predict progression of chronic kidney disease","volume":"26","author":"Wu","year":"2011","journal-title":"Nephrol Dial Transpl \u2013 Off Publ Eur Dial Transpl Assoc - Eur Renal Assoc"},{"issue":"3","key":"10.1016\/j.jfma.2019.03.005_bib36","doi-asserted-by":"crossref","first-page":"c99","DOI":"10.1159\/000097985","article-title":"Prospective randomized study evaluating the efficacy of the spherical adsorptive carbon AST-120 in chronic kidney disease patients with moderate decrease in renal function","volume":"105","author":"Shoji","year":"2007","journal-title":"Nephron Clin Pract"},{"issue":"3","key":"10.1016\/j.jfma.2019.03.005_bib37","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1744-9987.2007.00430.x","article-title":"AST-120, an oral adsorbent, delays the initiation of dialysis in patients with chronic kidney diseases","volume":"11","author":"Ueda","year":"2007","journal-title":"Ther Apher Dial"},{"issue":"3","key":"10.1016\/j.jfma.2019.03.005_bib38","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1053\/j.ajkd.2009.05.011","article-title":"Effect of a carbonaceous oral adsorbent on the progression of CKD: a multicenter, randomized, controlled trial","volume":"54","author":"Akizawa","year":"2009","journal-title":"Am J Kidney Dis \u2013 Off J Natl Kidney Found"},{"issue":"3","key":"10.1016\/j.jfma.2019.03.005_bib39","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1159\/000453673","article-title":"Effect of AST-120 in chronic kidney disease treatment: still a controversy?","volume":"135","author":"Yamaguchi","year":"2017","journal-title":"Nephron"},{"issue":"6","key":"10.1016\/j.jfma.2019.03.005_bib40","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1038\/sj.ki.5000115","article-title":"Free serum concentrations of the protein-bound retention solute p-cresol predict mortality in hemodialysis patients","volume":"69","author":"Bammens","year":"2006","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.jfma.2019.03.005_bib41","first-page":"1183","article-title":"Free p-cresylsulphate is a predictor of mortality in patients at different stages of chronic kidney disease","volume":"25","author":"Liabeuf","year":"2010","journal-title":"Nephrol Dial Transpl \u2013 Off Publ Eur Dial Transpl Assoc - Eur Renal Assoc"}],"container-title":["Journal of the Formosan Medical Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664618306089?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664618306089?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,12,3]],"date-time":"2020-12-03T23:58:06Z","timestamp":1607039886000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929664618306089"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":41,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S0929664618306089"],"URL":"https:\/\/doi.org\/10.1016\/j.jfma.2019.03.005","relation":{},"ISSN":["0929-6646"],"issn-type":[{"value":"0929-6646","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum indoxyl sulfate predicts adverse cardiovascular events in patients with chronic kidney disease","name":"articletitle","label":"Article Title"},{"value":"Journal of the Formosan Medical Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfma.2019.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Formosan Medical Association. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}